We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+11.54%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$2.67B
AUM Growth
-$255M
Cap. Flow
-$501M
Cap. Flow %
-18.76%
Top 10 Hldgs %
64.43%
Holding
673
New
208
Increased
118
Reduced
162
Closed
161

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$268M
2
AMZN icon
Amazon
AMZN
+$226M
3
BSX icon
Boston Scientific
BSX
+$55.2M
4
PYPL icon
PayPal
PYPL
+$42.9M
5
ADBE icon
Adobe
ADBE
+$33.3M

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$241M
2
MU icon
Micron Technology
MU
+$171M
3
INTC icon
Intel
INTC
+$163M
4
MSFT icon
Microsoft
MSFT
+$121M
5
AAPL icon
Apple
AAPL
+$112M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.16%
2 Technology 19.26%
3 Healthcare 6%
4 Financials 5.81%
5 Energy 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPGP icon
476
IPG Photonics
IPGP
$3.66B
$222K 0.01%
2,987
-12,537
-81% -$937K
OPY icon
477
Oppenheimer Holdings
OPY
$1.21B
$222K 0.01%
4,336
-3,801
-47% -$194K
BBWI icon
478
Bath & Body Works
BBWI
$3.89B
$220K 0.01%
+6,901
New +$229K
PEGA icon
479
Pegasystems
PEGA
$5.46B
$217K 0.01%
+5,936
New +$195K
FTNT icon
480
Fortinet
FTNT
$119B
$214K 0.01%
+2,762
New +$189K
TCPC icon
481
BlackRock TCP Capital
TCPC
$327M
$210K 0.01%
25,380
-13,152
-34% -$126K
LMND icon
482
Lemonade
LMND
$4.06B
$210K 0.01%
12,743
-31,911
-71% -$586K
AVNS
483
DELISTED
Avanos Medical
AVNS
$207K 0.01%
8,612
-8,423
-49% -$193K
HOPE icon
484
Hope Bancorp
HOPE
$1.8B
$204K 0.01%
16,262
-19,105
-54% -$234K
BRC icon
485
Brady Corp
BRC
$4.52B
$204K 0.01%
2,656
-15,430
-85% -$1.1M
CHDN icon
486
Churchill Downs
CHDN
$6.17B
$203K 0.01%
+1,502
New +$208K
NOAH
487
Noah Holdings
NOAH
$592M
$201K 0.01%
+16,299
New +$135K
RDUS
488
DELISTED
Radius Recycling
RDUS
$197K 0.01%
10,638
-3,880
-27% -$62K
OCSL icon
489
Oaktree Specialty Lending
OCSL
$1.12B
$197K 0.01%
+12,051
New +$206K
TEVA icon
490
Teva Pharmaceuticals
TEVA
$42.4B
$192K 0.01%
10,640
-19,067
-64% -$334K
PTVE
491
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$191K 0.01%
16,634
-15,808
-49% -$181K
LAUR icon
492
Laureate Education
LAUR
$5.1B
$190K 0.01%
11,431
-31,135
-73% -$476K
HAFC icon
493
Hanmi Financial
HAFC
$948M
$189K 0.01%
10,142
-4,514
-31% -$84.6K
SWI
494
DELISTED
SolarWinds Corporation Common Stock
SWI
$188K 0.01%
14,440
-12,643
-47% -$155K
PACK icon
495
Ranpak Holdings
PACK
$460M
$186K 0.01%
28,440
+3,918
+16% +$27K
MTW icon
496
Manitowoc
MTW
$701M
$186K 0.01%
19,295
– –
DNB
497
DELISTED
Dun & Bradstreet
DNB
$179K 0.01%
+15,520
New +$172K
NUVB icon
498
Nuvation Bio
NUVB
$2.3B
$161K 0.01%
70,401
+55,843
+384% +$170K
GTN icon
499
Gray Television
GTN
$497M
$159K 0.01%
29,748
-41,038
-58% -$211K
RWT
500
Redwood Trust
RWT
$588M
$140K 0.01%
18,157
-17,955
-50% -$131K
18 19
20
21 22

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q3 2024 Portfolio in Review

As of Q3 2024, Caxton Associates (New York) held 673 positions worth $2.67B, down 8.7% from $2.93B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Caxton Associates (New York) withdrew a net $501M in Q3 2024, closing 161 positions and reducing 162 holdings. Its most notable exit was Micron Technology, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Caxton Associates (New York) opened a new position in Boston Scientific worth $58.7M.

  • Caxton Associates (New York)'s largest Q3 2024 buy was Boston Scientific: 700,000 shares worth $58.7M.
  • Caxton Associates (New York) added most to Tesla in Q3 2024, an estimated $268M increase.
  • Caxton Associates (New York)'s biggest Q3 2024 reduction was Citigroup, cutting an estimated $241M.
  • Caxton Associates (New York) fully exited Micron Technology in Q3 2024, selling an estimated $171M.
  • Caxton Associates (New York)'s ten largest holdings make up 64% of its $2.67B portfolio in Q3 2024.
  • Caxton Associates (New York) opened 208 new positions and closed 161 in Q3 2024.
  • Caxton Associates (New York)'s portfolio value fell 8.7% quarter-over-quarter to $2.67B.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.